Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients

ABSTRACT: To analyze the different clinical and histologic types of cutaneous vasculitis in patients with primary Sjögren syndrome (SS), we investigated the clinical and immunologic characteristics of 558 consecutive patients with primary SS from our units and selected those with clinical evidence o...

Full description

Autores:
Ramos Casals, Manuel
Anaya Cabrera, Juan Manuel
García Carrasco, Mario
Rojas, José
Bové Boada, Albert
Claver Cercós, Gisela
Díaz, Jorge Aurelio
Herrero Vicent, Carmen
Font Franco, Josep
Tipo de recurso:
Article of investigation
Fecha de publicación:
2004
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/38745
Acceso en línea:
https://hdl.handle.net/10495/38745
Palabra clave:
Síndrome de Sjögren
Sjogren's Syndrome
Enfermedades de la Piel
Skin Diseases
Vasculitis
Estudios Transversales
Cross-Sectional Studies
https://id.nlm.nih.gov/mesh/D012859
https://id.nlm.nih.gov/mesh/D012871
https://id.nlm.nih.gov/mesh/D014657
https://id.nlm.nih.gov/mesh/D003430
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
id UDEA2_f1d6ddbc36f50751933609fb0f2b05dd
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/38745
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients
title Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients
spellingShingle Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients
Síndrome de Sjögren
Sjogren's Syndrome
Enfermedades de la Piel
Skin Diseases
Vasculitis
Estudios Transversales
Cross-Sectional Studies
https://id.nlm.nih.gov/mesh/D012859
https://id.nlm.nih.gov/mesh/D012871
https://id.nlm.nih.gov/mesh/D014657
https://id.nlm.nih.gov/mesh/D003430
title_short Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients
title_full Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients
title_fullStr Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients
title_full_unstemmed Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients
title_sort Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients
dc.creator.fl_str_mv Ramos Casals, Manuel
Anaya Cabrera, Juan Manuel
García Carrasco, Mario
Rojas, José
Bové Boada, Albert
Claver Cercós, Gisela
Díaz, Jorge Aurelio
Herrero Vicent, Carmen
Font Franco, Josep
dc.contributor.author.none.fl_str_mv Ramos Casals, Manuel
Anaya Cabrera, Juan Manuel
García Carrasco, Mario
Rojas, José
Bové Boada, Albert
Claver Cercós, Gisela
Díaz, Jorge Aurelio
Herrero Vicent, Carmen
Font Franco, Josep
dc.contributor.researchgroup.spa.fl_str_mv Biología Celular y Molecular CIB U. de A. U. del Rosario
dc.subject.decs.none.fl_str_mv Síndrome de Sjögren
Sjogren's Syndrome
Enfermedades de la Piel
Skin Diseases
Vasculitis
Estudios Transversales
Cross-Sectional Studies
topic Síndrome de Sjögren
Sjogren's Syndrome
Enfermedades de la Piel
Skin Diseases
Vasculitis
Estudios Transversales
Cross-Sectional Studies
https://id.nlm.nih.gov/mesh/D012859
https://id.nlm.nih.gov/mesh/D012871
https://id.nlm.nih.gov/mesh/D014657
https://id.nlm.nih.gov/mesh/D003430
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D012859
https://id.nlm.nih.gov/mesh/D012871
https://id.nlm.nih.gov/mesh/D014657
https://id.nlm.nih.gov/mesh/D003430
description ABSTRACT: To analyze the different clinical and histologic types of cutaneous vasculitis in patients with primary Sjögren syndrome (SS), we investigated the clinical and immunologic characteristics of 558 consecutive patients with primary SS from our units and selected those with clinical evidence of cutaneous lesions, excluding drug reactions and xeroderma. All patients fulfilled 4 or more of the diagnostic criteria for SS proposed by the European Community Study Group in 1993. A total of 89 (16%) patients presented with cutaneous involvement (88 female patients and 1 male; mean age, 51.8 yr). The main cutaneous involvement was cutaneous vasculitis, present in 52 (58%) patients. There were 51 (98%) female patients and 1 (2%) male, with a mean age at diagnosis of cutaneous vasculitis of 51 years (range, 20-80 yr). Fourteen presented with cryoglobulinemic vasculitis, 11 with urticarial vasculitis, and the remaining 26, with cutaneous purpura not associated with cryoglobulins. A skin biopsy specimen was obtained in 38 patients (73%). Involvement of small-sized vessels was observed in 36 (95%) patients (leukocytoclastic vasculitis), while the remaining 2 (5%) presented with medium-sized vessel vasculitis (necrotizing vasculitis). Patients with cutaneous vasculitis had a higher prevalence of articular involvement (50% vs 29%, p = 0.044), peripheral neuropathy (31% vs 4%, p < 0.001), Raynaud phenomenon (40% vs 15%, p = 0.008), renal involvement (10% vs 0%, p = 0.028), antinuclear antibodies (88% vs 60%, p = 0.002), rheumatoid factor (78% vs 48%, p = 0.004), anti-Ro/SS-A antibodies (70% vs 43%, p = 0.011), and hospitalization (25% vs 4%, p = 0.005) compared with SS patients without vasculitis. Six (12%) patients died, all of whom had multisystemic cryoglobulinemia. In conclusion, cutaneous involvement was detected in 16% of patients with primary SS, with cutaneous vasculitis being the most frequent process. The main characteristics of SS-associated cutaneous vasculitis were the overwhelming predominance of small versus medium vessel vasculitis and leukocytoclastic versus mononuclear vasculitis, with a higher prevalence of extraglandular and immunologic SS features. Small vessel vasculitis manifested as palpable purpura, urticarial lesions, or erythematosus maculopapules, with systemic involvement in 44% of patients in association with cryoglobulins in 30%. Life-threatening vasculitis was closely related to cryoglobulinemia.
publishDate 2004
dc.date.issued.none.fl_str_mv 2004
dc.date.accessioned.none.fl_str_mv 2024-03-26T00:21:26Z
dc.date.available.none.fl_str_mv 2024-03-26T00:21:26Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Ramos-Casals M, Anaya JM, García-Carrasco M, Rosas J, Bové A, Claver G, Diaz LA, Herrero C, Font J. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore). 2004 Mar;83(2):96-106. doi: 10.1097/01.md.0000119465.24818.98. PMID: 15028963.
dc.identifier.issn.none.fl_str_mv 0025-7974
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/38745
dc.identifier.doi.none.fl_str_mv 10.1097/01.md.0000119465.24818.98
dc.identifier.eissn.none.fl_str_mv 1536-5964
identifier_str_mv Ramos-Casals M, Anaya JM, García-Carrasco M, Rosas J, Bové A, Claver G, Diaz LA, Herrero C, Font J. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore). 2004 Mar;83(2):96-106. doi: 10.1097/01.md.0000119465.24818.98. PMID: 15028963.
0025-7974
10.1097/01.md.0000119465.24818.98
1536-5964
url https://hdl.handle.net/10495/38745
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Medicine
dc.relation.citationendpage.spa.fl_str_mv 106
dc.relation.citationissue.spa.fl_str_mv 2
dc.relation.citationstartpage.spa.fl_str_mv 96
dc.relation.citationvolume.spa.fl_str_mv 83
dc.relation.ispartofjournal.spa.fl_str_mv Medicine
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 11 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Lippincott, Williams & Wilkins
dc.publisher.place.spa.fl_str_mv Hagerstown, Estados Unidos
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/167f2c8e-b6b4-45db-b3fc-fa42c1143985/download
https://bibliotecadigital.udea.edu.co/bitstreams/5c85eaa1-a55f-4012-9c53-fabf1ac2b867/download
https://bibliotecadigital.udea.edu.co/bitstreams/15fef3e0-617f-4c27-8588-c7d644740cf7/download
https://bibliotecadigital.udea.edu.co/bitstreams/f222027f-053c-43a5-b996-09de12fd8255/download
https://bibliotecadigital.udea.edu.co/bitstreams/2572552e-64c4-4466-b96a-047f23bbb727/download
bitstream.checksum.fl_str_mv 1646d1f6b96dbbbc38035efc9239ac9c
8a4605be74aa9ea9d79846c1fba20a33
8fd76f6388c9f569fcf8379468d52ec7
f9a2ffc332de94d4d540334fa393c67d
d0452e2106b958c494f3b807de77b056
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052416259063808
spelling Ramos Casals, ManuelAnaya Cabrera, Juan ManuelGarcía Carrasco, MarioRojas, JoséBové Boada, AlbertClaver Cercós, GiselaDíaz, Jorge AurelioHerrero Vicent, CarmenFont Franco, JosepBiología Celular y Molecular CIB U. de A. U. del Rosario2024-03-26T00:21:26Z2024-03-26T00:21:26Z2004Ramos-Casals M, Anaya JM, García-Carrasco M, Rosas J, Bové A, Claver G, Diaz LA, Herrero C, Font J. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore). 2004 Mar;83(2):96-106. doi: 10.1097/01.md.0000119465.24818.98. PMID: 15028963.0025-7974https://hdl.handle.net/10495/3874510.1097/01.md.0000119465.24818.981536-5964ABSTRACT: To analyze the different clinical and histologic types of cutaneous vasculitis in patients with primary Sjögren syndrome (SS), we investigated the clinical and immunologic characteristics of 558 consecutive patients with primary SS from our units and selected those with clinical evidence of cutaneous lesions, excluding drug reactions and xeroderma. All patients fulfilled 4 or more of the diagnostic criteria for SS proposed by the European Community Study Group in 1993. A total of 89 (16%) patients presented with cutaneous involvement (88 female patients and 1 male; mean age, 51.8 yr). The main cutaneous involvement was cutaneous vasculitis, present in 52 (58%) patients. There were 51 (98%) female patients and 1 (2%) male, with a mean age at diagnosis of cutaneous vasculitis of 51 years (range, 20-80 yr). Fourteen presented with cryoglobulinemic vasculitis, 11 with urticarial vasculitis, and the remaining 26, with cutaneous purpura not associated with cryoglobulins. A skin biopsy specimen was obtained in 38 patients (73%). Involvement of small-sized vessels was observed in 36 (95%) patients (leukocytoclastic vasculitis), while the remaining 2 (5%) presented with medium-sized vessel vasculitis (necrotizing vasculitis). Patients with cutaneous vasculitis had a higher prevalence of articular involvement (50% vs 29%, p = 0.044), peripheral neuropathy (31% vs 4%, p < 0.001), Raynaud phenomenon (40% vs 15%, p = 0.008), renal involvement (10% vs 0%, p = 0.028), antinuclear antibodies (88% vs 60%, p = 0.002), rheumatoid factor (78% vs 48%, p = 0.004), anti-Ro/SS-A antibodies (70% vs 43%, p = 0.011), and hospitalization (25% vs 4%, p = 0.005) compared with SS patients without vasculitis. Six (12%) patients died, all of whom had multisystemic cryoglobulinemia. In conclusion, cutaneous involvement was detected in 16% of patients with primary SS, with cutaneous vasculitis being the most frequent process. The main characteristics of SS-associated cutaneous vasculitis were the overwhelming predominance of small versus medium vessel vasculitis and leukocytoclastic versus mononuclear vasculitis, with a higher prevalence of extraglandular and immunologic SS features. Small vessel vasculitis manifested as palpable purpura, urticarial lesions, or erythematosus maculopapules, with systemic involvement in 44% of patients in association with cryoglobulins in 30%. Life-threatening vasculitis was closely related to cryoglobulinemia.COL000096211 páginasapplication/pdfengLippincott, Williams & WilkinsHagerstown, Estados Unidoshttps://creativecommons.org/licenses/by-nc-nd/4.0/http://creativecommons.org/licenses/by-nc-nd/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patientsArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionSíndrome de SjögrenSjogren's SyndromeEnfermedades de la PielSkin DiseasesVasculitisEstudios TransversalesCross-Sectional Studieshttps://id.nlm.nih.gov/mesh/D012859https://id.nlm.nih.gov/mesh/D012871https://id.nlm.nih.gov/mesh/D014657https://id.nlm.nih.gov/mesh/D003430Medicine10629683MedicinePublicationCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8927https://bibliotecadigital.udea.edu.co/bitstreams/167f2c8e-b6b4-45db-b3fc-fa42c1143985/download1646d1f6b96dbbbc38035efc9239ac9cMD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/5c85eaa1-a55f-4012-9c53-fabf1ac2b867/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADORIGINALAnayaJuan_2004_CutaneousVasculitisPrimary.pdfAnayaJuan_2004_CutaneousVasculitisPrimary.pdfArtículo de investigaciónapplication/pdf111797https://bibliotecadigital.udea.edu.co/bitstreams/15fef3e0-617f-4c27-8588-c7d644740cf7/download8fd76f6388c9f569fcf8379468d52ec7MD51trueAnonymousREADTEXTAnayaJuan_2004_CutaneousVasculitisPrimary.pdf.txtAnayaJuan_2004_CutaneousVasculitisPrimary.pdf.txtExtracted texttext/plain64692https://bibliotecadigital.udea.edu.co/bitstreams/f222027f-053c-43a5-b996-09de12fd8255/downloadf9a2ffc332de94d4d540334fa393c67dMD54falseAnonymousREADTHUMBNAILAnayaJuan_2004_CutaneousVasculitisPrimary.pdf.jpgAnayaJuan_2004_CutaneousVasculitisPrimary.pdf.jpgGenerated Thumbnailimage/jpeg16196https://bibliotecadigital.udea.edu.co/bitstreams/2572552e-64c4-4466-b96a-047f23bbb727/downloadd0452e2106b958c494f3b807de77b056MD55falseAnonymousREAD10495/38745oai:bibliotecadigital.udea.edu.co:10495/387452025-03-26 22:00:30.431https://creativecommons.org/licenses/by-nc-nd/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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